Aurobindo Pharmaceuticals has done all the wrong things on the charts, made a rounding top, a bearish head and shoulder, breaking down from support levels and giving a message that a much deeper correction is still coming in, says Sudarshan Sukhani of s2analytics.com.
Phani Sekhar, Fund Manager, Angel Broking is of the view that investor can hold Aurobindo Pharmaceuticals.
In CNBC-TV18's popular show Bull's Eye, Lancelot D Cunha, ITI Wealth Management shares trading strategy of the day.
In CNBC-TV18's popular show Bull's Eye, Nooresh Merani, AMSEC Research shares trading strategy of the day.
In an interview with CNBC-TV18, portfolio manager PN Vijay, spoke about his multi-bagger ideas and his reading of the market.